期刊文献+

老年男性2型糖尿病患者血浆Hcy的表达水平与骨密度的相关性分析 被引量:2

Association between plasma Hcy and bone mineral density in elderly male patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的:探讨血浆同型半胱氨酸(Hcy)与老年男性2型糖尿病患者骨密度(BMD)的关系。方法:收集老年男性2型糖尿病患者45例,根据BMD水平分为骨量减少组(A组,24例)、骨量正常组(B组,21例)。检测各组患者的血浆Hcy水平、体质量指数(BMI)、血钙、血磷、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)及高密度脂蛋白胆固醇(HDL-C),2组之间进行比较。结果:A组的BMD和BMI明显低于B组,差异有统计学意义(P<0.05);A组的Hcy明显高于B组,差异有统计学意义(P<0.05);2组的血钙、血磷、TC、TG、LDL-C及HDL-C比较差异均无统计学意义(P>0.05);Pearson相关性分析显示,BMD与BMI呈正相关(r=0.26,P<0.05),与Hcy呈负相关(r=-0.579,P<0.05)。结论:BMI下降、血浆Hcy水平升高可能与老年男性2型糖尿病患者BMD的降低相关。 Objective: To investigate the correlation between plasma Hcy and bone mineral density (BMD)in elderly male patients with type 2 diabetes mellitus (T2DM). Methods: Forty-five elderly male patients with T2DM were divided into osteopenia group (group A, 24 patients) and normal group (group B, 21 patients) ac- cording to the level of BMD. Correlations between Hcy, body mass index (BMI), blood calcium, blood phos- phorus, total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) were analyzed in group A and groupB. Results: BMD and BMI in group A were significantly lower than those in group B (P〈0.05). Hcy in group A was significantly higher than that in group B (P〈0.05). Blood calcium, blood phosphorus, TC, TG, HDL-C and LDL-C had no statistically significant differ- ence between two groups (/〉〉0.05). Pearson correlation analysis showed that BMD was positively correlated with BMI (r=0.26, P〈0.05), and negatively correlated with Hcy (r=-0.579, P〈0.05). Conclusion: The decline of BMI and incline of plasma Hcy may associate with decreasement of BMD in elderly male patients with T2DM.
作者 马翠 马文杰
出处 《温州医科大学学报》 CAS 2016年第7期533-535,共3页 Journal of Wenzhou Medical University
关键词 老年男性 糖尿病 2型 骨密度 同型半胱氨酸 elderly male diabetes mellitus, type 2 bone mineral density homocysteine
  • 相关文献

参考文献12

  • 1ITO T, SCHAFFER S W, AZUMA J. The potential useful-ness of taurine ondiabetes mellitus and its complications[J]. Amino Acids, 2012, 42(5): 1529-1539.
  • 2AKPOLAT V, BILGIN H M, CELIK M Y, et al. An eval- uation of nitric oxide, folate, homocysteine levels and lipid peroxidation in postmenopausal osteoporosis[J]. Adv Clin Exp Med, 2013, 22(3): 403-409.
  • 3马剑侠,薛鹏,王燕,鲍晓雪,李玉坤.老年糖尿病患者血浆同型半胱氨酸与骨密度的相关性[J].中国老年学杂志,2015,35(10):2672-2673. 被引量:5
  • 4中国人骨质疏松症建议诊断标准(第二稿)[J].中国骨质疏松杂志,2000,6(1):1-3. 被引量:1235
  • 5尹嘉晶,彭永德.糖尿病与骨质疏松[J].中华内分泌代谢杂志,2014,30(5):449-452. 被引量:46
  • 6HERRMANN M, WIDMANN T, HERRMANN W. Homo- cysteine--a newly recognised risk factor for osteoporosis [J], Clin Chem Lab Med, 2005, 43(10): 111 l-1117.
  • 7KIM D J, KOH J M, LEE O, et al. Homocysteine enhances apoptosis in human bone marrow stromal cells[J]. Bone, 2006, 39(3): 582-590.
  • 8何玉玲,李勇杰,苏宏业.2型糖尿病患者血浆同型半胱氨酸水平的变化及其相关因素分析[J].广西医科大学学报,2014,31(4):621-623. 被引量:3
  • 9HERRMANN M, WIDMANN T, COLAIANNI G, et al. In- creased osteoclast activity in the presence of increased ho- mocysteine concentrations[J]. Clin Chem, 2006, 51(12): 2348-2354.
  • 10KOH J M, LEE Y S, KIM Y S, et al. Homocysteine enhanc- es bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation [J]. J Bone Miner Res, 2006, 21(7): 1003-1011.

二级参考文献89

  • 1汤群,陆国平,吴春芳,王毓明,黄霞,龚兰生.同型半胱氨酸与叶酸、维生素B_(12)及维生素B_6的关系[J].中华心血管病杂志,2004,32(9):812-815. 被引量:78
  • 2张颖,彭永德.骨质疏松症治疗新药特立帕肽[J].世界临床药物,2004,25(12):725-729. 被引量:8
  • 3谷伟军,陆菊明.同型半胱氨酸与糖尿病及慢性血管并发症[J].国际内分泌代谢杂志,2006,26(2):80-83. 被引量:27
  • 4朱翔,章秋.糖尿病性骨质疏松及其影响因素[J].实用糖尿病杂志,2006,2(4):6-8. 被引量:33
  • 5Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteopomsis: 2001 edition, with selected updates for 2003. Endocr Pract, 2003, 9(6) : 544-564.
  • 6van Meurs JB, Dhonukshe-Rutten RA. Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med, 2004, 350(20): 2033-2041.
  • 7McLean P,.R, Jacques PF, Selhub J, et al. Homocystelne as a predictive factor for hip fracture in older persons. N Engl J Med, 2004, 350(20): 2042-2049.
  • 8Sato Y, Iwamoto J, Kanoko T, et al. Homoeyselne as a predictive factor for hip fracture in elderly women with Parkinson's disease. Am J Med, 2005, 118: 1250-1255.
  • 9Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 1995, 10(1): 111-113.
  • 10Miyao hi, Morita H, Hosoi T, et al. Association of methylenetetrahydrofolate reductase ( MTHFR ) polymorphism with bone mineral density Jn postmenopausal Japanese women. Caleif Tissue Int, 2000, 66(3) : 190-194.

共引文献1291

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部